Invention Grant
US07655652B2 Imidazolo-5-yl-2-anilinopyrimidines as agents for the inhibition of cell proliferation
失效
咪唑并-5-基-2-苯胺基嘧啶作为抑制细胞增殖的试剂
- Patent Title: Imidazolo-5-yl-2-anilinopyrimidines as agents for the inhibition of cell proliferation
- Patent Title (中): 咪唑并-5-基-2-苯胺基嘧啶作为抑制细胞增殖的试剂
-
Application No.: US10586954Application Date: 2005-01-31
-
Publication No.: US07655652B2Publication Date: 2010-02-02
- Inventor: David Michael Andrews , Maurice Raymond Finlay , Clive Green
- Applicant: David Michael Andrews , Maurice Raymond Finlay , Clive Green
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agency: Morgan, Lewis & Bockius LLP
- Priority: GB0402277.8 20040203; GB0411998.8 20040528
- International Application: PCT/GB2005/000303 WO 20050131
- International Announcement: WO2005/075461 WO 20050818
- Main IPC: C07D403/04
- IPC: C07D403/04 ; A61K31/505
Abstract:
Compounds of the formula (I), wherein variable groups are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti cell proliferation) effect in a warm blooded animal, such as man.
Public/Granted literature
- US20070161615A1 Chemical compounds Public/Granted day:2007-07-12
Information query
